Prolonged continuous infusion of low-dose rIL-2.
Janssen
R A
RA
Buter
J
J
The
T H
TH
Mulder
N H
NH
de Leij
L
L
D002292:Carcinoma, Renal Cell / Q000276:immunology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D008545:Melanoma / Q000276:immunology*; D011994:Recombinant Proteins / Q000008:administration & dosage; D013601:T-Lymphocytes / Q000276:immunology
D007376:Interleukin-2; D011994:Recombinant Proteins